➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
Moodys
Merck
Johnson and Johnson

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

LEUCOVORIN CALCIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for leucovorin calcium and what is the scope of freedom to operate?

Leucovorin calcium is the generic ingredient in three branded drugs marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Fresenius Kabi Usa, Ingenus Pharms Llc, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Am Regent, Mylan Labs Ltd, Sagent Pharms, Sagent Pharms Inc, Glaxosmithkline, Ani Pharms Inc, Barr, Epic Pharma Llc, Hikma, Par Pharm, and Xanodyne Pharm, and is included in forty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for leucovorin calcium. Thirteen suppliers are listed for this compound.

Drug Prices for LEUCOVORIN CALCIUM

See drug prices for LEUCOVORIN CALCIUM

Recent Clinical Trials for LEUCOVORIN CALCIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Samsung Medical CenterPhase 2
NRG OncologyPhase 2/Phase 3
New York State Institute for Basic ResearchPhase 2

See all LEUCOVORIN CALCIUM clinical trials

Pharmacology for LEUCOVORIN CALCIUM
Drug ClassFolate Analog
Medical Subject Heading (MeSH) Categories for LEUCOVORIN CALCIUM

US Patents and Regulatory Information for LEUCOVORIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmachemie LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 073101-001 Mar 28, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline WELLCOVORIN leucovorin calcium INJECTABLE;INJECTION 087439-001 Oct 19, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 072735-001 Feb 22, 1993 RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int LEUCOVORIN CALCIUM leucovorin calcium INJECTABLE;INJECTION 089384-001 Sep 14, 1987 AP RX No Yes   Start Trial   Start Trial   Start Trial
Epic Pharma Llc LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 074544-002 Aug 28, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
Abic LEUCOVORIN CALCIUM leucovorin calcium INJECTABLE;INJECTION 089352-001 Jun 1, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Moodys
Colorcon
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.